clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00663221 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | France | Q142 |
P4135 | maximum age | 65 | |
P1050 | medical condition | osteoporosis | Q165328 |
P2899 | minimum age | 50 | |
P1132 | number of participants | 56 | |
P4844 | research intervention | calcium oxalate | Q412399 |
(5R)-24,25-Dihydroxyvitamin D | Q27161510 | ||
P580 | start time | 2008-03-01 | |
P8363 | study type | interventional study | Q78089383 |
Search more.